Imeka’s main goal is to play an influential role in the search and development of cures for brain disease. The technology Imeka has pioneered to enhance white matter imaging, albeit very niche and focused, has applications in almost all brain disease areas.
This being said, we don’t think we hold all the answers, but we believe we are the best in the world at looking at white matter and brain connectivity, and that this is an important part of the equation.
Imeka’s technology is only surpassed in ingenuity by its team, which includes Maxime Descoteaux, Ph.D., founder & CSO of Imeka. Maxime is an internationally renowned leader in medical imaging and diffusion MRI, acquisition, reconstruction, visualization and processing in many clinical applications.